0001193125-26-182316.txt : 20260427 0001193125-26-182316.hdr.sgml : 20260427 20260427165226 ACCESSION NUMBER: 0001193125-26-182316 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260424 FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATA NATHAN L. CENTRAL INDEX KEY: 0002013987 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41359 FILM NUMBER: 26901783 MAIL ADDRESS: STREET 1: 7708 MARKER ROAD CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELITE BIO, INC CENTRAL INDEX KEY: 0001889109 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12750 HIGH BLUFF DRIVE SUITE 475 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-246-6240 MAIL ADDRESS: STREET 1: 12750 HIGH BLUFF DRIVE SUITE 475 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 ownership.xml 4 X0609 4 2026-04-24 0001889109 BELITE BIO, INC BLTE 0002013987 MATA NATHAN L. false 7708 MARKER ROAD SAN DIEGO CA 92130 false true false false Chief Scientific Officer true American depositary share 2026-04-24 4 S false 74 157.8646 D 9592 D American depositary share 2026-04-24 4 S false 190 158.6468 D 9402 D American depositary share 2026-04-24 4 S false 375 159.4601 D 9027 D American depositary share 2026-04-24 4 S false 330 160.3979 D 8697 D American depositary share 2026-04-24 4 S false 28 161.2216 D 8669 D American depositary share 2026-04-24 4 S false 3 162.5300 D 8666 D Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $157.81 to $157.9928. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $158.025 to $158.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $159.0063 to $159.9623. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $160 to $160.85. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $161.08 to $161.3562. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. /s/ Nathan L. Mata 2026-04-27